MedTrace Logo

Prevention of Paclitaxel Neuropathy With Cryotherapy

NCT02230319 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2015-10-01

No results posted yet for this study

Summary

The purpose of this study is to determine if cryotherapy can effectively decrease the rate of neuropathy in patients undergoing weekly paclitaxel treatments.

Conditions

Interventions

OTHER

Cryotherapy

DRUG

Paclitaxel

Sponsors & Collaborators

  • Inova Health Care Services

    collaborator OTHER

  • Medical Oncology & Hematology Associates of Northern Virginia

    lead OTHER

Principal Investigators

  • Mary J Wilkinson, MD · Medical Oncology & Hematology Associates of Northern Virginia

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-09-30
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02230319 on ClinicalTrials.gov